NuVasive (NUVA) Debt to Equity Ratio

Current and historical debt to equity ratio values for NuVasive (NUVA) over the last 10 years.

Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $3.435B $0.962B
NUVASIVE is a medical device company focused on the design, development and marketing of products for the surgical treatment of spine disorders. The Company's product portfolio is focused on applications in the over $4.2 billion U.S. spine fusion market. The Company's current principal product offering includes a minimally disruptive surgical platform called Maximum Access Surgery, or MAS, as well as a growing offering of cervical and motion preservation products.